Journal
JOURNAL OF THORACIC ONCOLOGY
Volume 14, Issue 10, Pages S405-S405Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2019.08.827
Keywords
Pembrolizumab; lenvatinib; first-line